134 related articles for article (PubMed ID: 27998393)
1. Extracellular S100A4 negatively regulates osteoblast function by activating the NF-κB pathway.
Kim H; Lee YD; Kim MK; Kwon JO; Song MK; Lee ZH; Kim HH
BMB Rep; 2017 Feb; 50(2):97-102. PubMed ID: 27998393
[TBL] [Abstract][Full Text] [Related]
2. S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway.
Zhu Y; Zhou Y; Zhou X; Guo Y; Huang D; Zhang J; Wang C; Cai L
BMC Cancer; 2018 Jul; 18(1):763. PubMed ID: 30045697
[TBL] [Abstract][Full Text] [Related]
3. S100A4: a novel negative regulator of mineralization and osteoblast differentiation.
Duarte WR; Shibata T; Takenaga K; Takahashi E; Kubota K; Ohya K; Ishikawa I; Yamauchi M; Kasugai S
J Bone Miner Res; 2003 Mar; 18(3):493-501. PubMed ID: 12619934
[TBL] [Abstract][Full Text] [Related]
4. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
Shim KS; Lee B; Ma JY
BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
[TBL] [Abstract][Full Text] [Related]
5. Extracellular role of S100A4 calcium-binding protein in the periodontal ligament.
Duarte WR; Iimura T; Takenaga K; Ohya K; Ishikawa I; Kasugai S
Biochem Biophys Res Commun; 1999 Feb; 255(2):416-20. PubMed ID: 10049723
[TBL] [Abstract][Full Text] [Related]
6. S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells.
Kato C; Kojima T; Komaki M; Mimori K; Duarte WR; Takenaga K; Ishikawa I
Biochem Biophys Res Commun; 2005 Jan; 326(1):147-53. PubMed ID: 15567164
[TBL] [Abstract][Full Text] [Related]
7. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
8. Genistein induces oestrogen receptor-α gene expression in osteoblasts through the activation of mitogen-activated protein kinases/NF-κB/activator protein-1 and promotes cell mineralisation.
Liao MH; Tai YT; Cherng YG; Liu SH; Chang YA; Lin PI; Chen RM
Br J Nutr; 2014 Jan; 111(1):55-63. PubMed ID: 23829885
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
[TBL] [Abstract][Full Text] [Related]
10. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.
Chuong C; Katz J; Pauley KM; Bulosan M; Cha S
J Cell Physiol; 2009 Nov; 221(2):430-4. PubMed ID: 19591173
[TBL] [Abstract][Full Text] [Related]
11. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
12. Metformin alleviates hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts through inhibiting the TLR4 signaling pathway.
Zheng L; Shen X; Ye J; Xie Y; Yan S
Life Sci; 2019 Jan; 216():29-38. PubMed ID: 30414431
[TBL] [Abstract][Full Text] [Related]
13. Advanced oxidation protein products inhibit proliferation and differentiation of rat osteoblast-like cells via NF-kappaB pathway.
Zhong ZM; Bai L; Chen JT
Cell Physiol Biochem; 2009; 24(1-2):105-14. PubMed ID: 19590198
[TBL] [Abstract][Full Text] [Related]
14. Monotropein attenuates ovariectomy and LPS-induced bone loss in mice and decreases inflammatory impairment on osteoblast through blocking activation of NF-κB pathway.
He YQ; Yang H; Shen Y; Zhang JH; Zhang ZG; Liu LL; Song HT; Lin B; Hsu HY; Qin LP; Han T; Xin HL; Zhang QY
Chem Biol Interact; 2018 Aug; 291():128-136. PubMed ID: 29908987
[TBL] [Abstract][Full Text] [Related]
15. Irradiation inhibits the maturation and mineralization of osteoblasts via the activation of Nrf2/HO-1 pathway.
Kook SH; Kim KA; Ji H; Lee D; Lee JC
Mol Cell Biochem; 2015 Dec; 410(1-2):255-66. PubMed ID: 26346162
[TBL] [Abstract][Full Text] [Related]
16. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
17. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
[TBL] [Abstract][Full Text] [Related]
18. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway.
Hess K; Ushmorov A; Fiedler J; Brenner RE; Wirth T
Bone; 2009 Aug; 45(2):367-76. PubMed ID: 19414075
[TBL] [Abstract][Full Text] [Related]
19. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Okamura H; Yoshida K; Ochiai K; Haneji T
Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
[TBL] [Abstract][Full Text] [Related]
20. Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing.
Auh QS; Park KR; Yun HM; Lim HC; Kim GH; Lee DS; Kim YC; Oh H; Kim EC
Oncotarget; 2016 Nov; 7(48):78320-78330. PubMed ID: 27713171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
